Skip to main content Accessibility help
×
Home

Tayside–Fife clinical trial of cognitive–behavioural therapy for medication-resistant psychotic symptoms: Results to 3-month follow-up

  • Robert C. Durham (a1), Moyra Guthrie (a1), R. Victor Morton (a1), David A. Reid (a1), Linda R. Treliving (a1), David Fowler (a2) and Ranald R. MacDonald (a3)...

Abstract

Background

Evidence for the efficacy of cognitive–behavioural therapy for schizophrenia is promising but evidence for clinical effectiveness is limited.

Aims

To test the effectiveness of cognitive–behavioural therapy delivered by clinical nurse specialists in routine practice.

Method

Of 274 referrals, 66 were allocated randomly to 9 months of treatment as usual (TAU), cognitive–behavioural therapy plus TAU (CBT) or supportive psychotherapy plus TAU (SPT) and followed up for 3 months.

Results

Treatment effects were modest but the CBT condition gave significantly greater improvement in overall symptom severity than the SPT or TAU conditions combined (F (1,53)=4.14; P=0.05). Both the CBT and SPT conditions combined gave significantly greater improvement in severity of delusions than did the TAU condition (F (1,53)=4.83; P=0.03). Clinically significant improvements were achieved by 7/21 in the CBT condition (33%), 3/19 in the SPT condition (16%) and 2/17 in the TAU condition (12%).

Conclusions

Cognitive–behavioural therapy delivered by clinical nurse specialists is a helpful adjunct to routine care for some people with chronic psychosis.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Tayside–Fife clinical trial of cognitive–behavioural therapy for medication-resistant psychotic symptoms
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Tayside–Fife clinical trial of cognitive–behavioural therapy for medication-resistant psychotic symptoms
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Tayside–Fife clinical trial of cognitive–behavioural therapy for medication-resistant psychotic symptoms
      Available formats
      ×

Copyright

Corresponding author

Rob Durham, Department of Psychiatry, Ninewells Hospital & Medical School, Dundee DDI 9SY, Scotland, UK. E-mail: r.c.durham@dundee.ac.uk

Footnotes

Hide All

Declaration of interest

None.

Footnotes

References

Hide All
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM–IV). Washington, DC: APA.
Atkins, M., Burgess, A., Bottom ley, C., et al (1997) Chlorpromazine equivalents: a consensus of opinion for both clinical and research applications. Psychiatric Bulletin, 21, 224226.
Barnes, T. & Nelson, H. (1994) The Assessment of Psychoses: A Practical Handbook. London: Chapman and Hall Medical.
Bateman, A. & Holmes, J. (1995) Introduction to Psychoanalysis. London: Routledge.
Cohen, J. (1992) A power primer. Psychological Bulletin, 112, 155159.
Cormac, I., Jones, C., Campbell, C., et al (2002) Cognitive behaviour therapy for schizophrenia. Cochrane Library, issue 4. Oxford: Update Software.
De Jonghe, F. (1993) Psychoanalytic supportive psychotherapy. Journal of the American Psychoanalytic Association, 42, 421425.
Drake, R., Haddock, G., Hopkins, R., et al (1998) The measurement of outcome in schizophrenia. In Outcome and Innovation in Psychological Treatment of Schizophrenia (eds Wykes, T., Tarrier, N. & Lewis, S.), pp. 4357. Chichester: John Wiley & Sons.
Durham, R., Swan, J. & Fisher, P. (2000) Complexity and collaboration in routine practice of CBT: what doesn't work with whom and how might it work better? Journal of Mental Health, 9, 429444.
Endicott, J., Spitzer, R., Fleiss, J., et al (1976) Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry, 33, 766771.
Fowler, D., Garety, P. A. & Kuipers, L. (1995) Cognitive Behaviour Therapy for People with Psychosis: A Clinical Handbook. Chichester: John Wiley & Sons.
Garfield, D. (1995) Unbearable Affect: A Guide to the Psychotherapy of Psychosis. Chichester: John Wiley & Sons.
Guy, W. (1976) Assessment Manual for Psychopharmacology. Washington, DC: US Government Printing Office.
Haddock, G., McCarron, J., Tarrier, N., et al (1999) Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychological Medicine, 29, 879889.
Johnson, T. (1992) Statistical methods in clinical trials. In Research Methods in Psychiatry (eds Freeman, C. J. & Tyrer, P.), pp. 2461. London: Gaskell.
Kane, J. M. (1996) Treatment-resistant schizophrenic patients. Journal of Clinical Psychiatry, 57 (suppl. 9), 3540.
Kay, S., Fiszbein, A. & Opler, L. (1987) The Positive and Negative Syndrome Scale (PANSS). Schizophrenia Bulletin, 13, 261273.
Kingdon, D. G. & Turkington, D. (1994) Cognitive–Behavioural Therapy of Schizophrenia. Hove: Lawrence Erlbaum.
Kuipers, E., Garety, P., Fowler, D., et al (1997) London–East Anglia randomised controlled trial of cognitive–behavioural therapy for psychosis. 1: effects of the treatment phase. British Journal of Psychiatry. 171, 319327.
Kuipers, E., Fowler, D., Garety, P., et al (1998) London–East Anglia randomised controlled trial of cognitive behavioural therapy for psychosis III: follow-up and economic evaluation at 18 months. British Journal of Psychiatry, 173, 6168.
Luborsky, L., Barber, J. P., Siqueland, L., et al (1996) The revised Helping Alliance Questionnaire (HAQ–11). Journal of Psychotherapy Practice and Research, 5, 260271.
Pilling, S., Bebbington, P., Kuipers, E., et al (2002) Psychological treatments in schizophrenia: 1. Metaanalysis of family intervention and cognitive behaviour therapy. Psychological Medicine, 32, 763782.
Sensky, T., Turkington, D., Kingdon, D., et al (2000) A randomized controlled trial of cognitive–behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry, 57, 165172.
Startup, M., Jackson, M. & Pearce, E. (2002) Assessing therapist adherence to cognitive–behaviour therapy for psychosis. Behavioural and Cognitive Psychotherapy, 30, 329339.
Tarrier, N. (1992) Management and modification of residual psychotic symptoms. In Innovations in the Psychological Management of Schizophrenia (eds Birchwood, M. & Tarrier, N.), pp. 147170. Chichester: John Wiley & Sons.
Tarrier, N., Beckett, R., Harwood, S., et al (1993) Atrial of two cognitive–behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients: 1. Outcome. British Journal of Psychiatry, 162, 524532.
Tarrier, N., Yusupoff, L., Kinney, C., et al (1998) Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ, 317, 303307.
Turkington, D., Kingdon, D. & Turner, T. (2002) Effectiveness of a brief cognitive–behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry, 180, 523527.
Vallis, T. M., Show, B. F. & Dobson, K. S. (1986) The Cognitive Therapy Rating Scale: psychometric properties. Journal of Consulting and Clinical Psychology, 54, 381385.
Volavka, J., Czobor, P., Sheitman, B., et al (2002) Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. American Journal of Psychiatry, 159, 255262.
World Health Organization (1992) The ICD–10 Classification of Mental and Behavioural Disorders. Geneva: WHO.

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Tayside–Fife clinical trial of cognitive–behavioural therapy for medication-resistant psychotic symptoms: Results to 3-month follow-up

  • Robert C. Durham (a1), Moyra Guthrie (a1), R. Victor Morton (a1), David A. Reid (a1), Linda R. Treliving (a1), David Fowler (a2) and Ranald R. MacDonald (a3)...
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *